Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis.

BMC pulmonary medicine - 5 Sept 2012

Marson Fernando A L, Bertuzzo Carmen S, Ribeiro Antônio F, Ribeiro José D

Abstract excerpt

BACKGROUND: The most common cystic fibrosis (CF) manifestation is the progressive chronic obstructive pulmonary disease caused by deficiency, dysfunction, or absence of the CFTR (Cystic Fibrosis Transmembrane Regulator) protein on the apical surface of the cells in the respiratory tract. The use of bronchodilators (BD), and inhaled corticosteroids (IC) have been suggested for the management of airway inflammation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bronchodilator Agents
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Receptors, Adrenergic, beta-2

Share to Severity of Illness Index

Share to Spirometry

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 22950544
DOI: 10.1186/1471-2466-12-50
PMCID: PMC3558405

Genes

ADRB2
CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis.PMID 22950544Read ↗

Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.Semantic proximity Read ↗

Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease.Semantic proximity Read ↗

Beta2-adrenergic receptor gene haplotypes and bronchodilator response in Egyptian patients with chronic obstructive pulmonary disease.Semantic proximity Read ↗

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.Semantic proximity Read ↗

Effect of ADRB2 (adrenergic receptor β2) gene polymorphisms on the occurrence of asthma and on the response to nebulized salbutamol in South Indian patients with bronchial asthma.Semantic proximity Read ↗

Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.Semantic proximity Read ↗

Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.Semantic proximity Read ↗

ADRB2 and ADCY9 Sequence Variations in Brazilian Asthmatic PatientsSemantic proximity Read ↗

Beta 2 adrenergic receptor polymorphisms in cystic fibrosis.Semantic proximity Read ↗

B2 adrenergic receptor gene polymorphism effect on childhood asthma severity and response to treatment.Semantic proximity Read ↗

Beta2-adrenoceptor polymorphisms and obstructive airway diseases: important issues of study design.Semantic proximity Read ↗

Beta 2 Adrenergic Receptor Genetic Polymorphisms in Bronchial Asthma: Relationship to Disease Risk, Severity, and Treatment Response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.